Press releases

Release issued 27th April 2006

York, UK—Pharmalicensing announced today that it has completed revision of its best-selling Partneringdesk Deals and Alliances therapy reports (http://partneringdesk.com). The reports cover pharma and biotech deals from January 2001 to March 2006, and span over fourteen therapeutic areas including dermatology, oncology, genitourinary, central nervous system and cardiovascular disease amongst others.

Partneringdesk Deals and Alliances therapy reports provide a comprehensive summary of the deals and alliances announced in the therapeutic area in the last five years, in a clear and accessible printable format. In each report, an introduction discusses trends in deal making in the last five years and chapters include deals sorted by company, development stage, deal type and industry sector. Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments.

"The Deals and Alliances therapy reports provide an excellent value overview of the partnering strategies within therapy areas," said Suzanne Elvidge, Head of Publishing. "The graphs in the introduction provide snapshots of deal trends, and the detailed deal breakdown gives readers access to in-depth deal descriptions."

For more information on Partneringdesk Deals and Alliances therapy reports or other products, go to pharmalicensing.com/desk, or contact the Partneringdesk team on tel: +44 1904 520460 or email: partneringdesk@pharmalicensing.com.

Pharmalicensing (pharmalicensing.com), based in York, UK, is the world's number one partnering resource for the biopharmaceutical industry. Pharmalicensing provides pharmaceutical companies with a wide-ranging forum to exchange partnering wants and needs with a global audience.

Bridgehead International is a leading biopharmaceutical consultancy group, offering a range of services designed to assist clients in achieving extraordinary growth across the product and technology value chain, through three divisions: Bridgehead Consulting; Healthcare Education Services; and Pharmalicensing.

Contact: Suzanne Elvidge, Head of Publishing (suzanne.elvidge@bridgehead.com; Tel +44 1904 520464)

(5th January 2012) Innovaro Announces Successful Sale of the Waycool Portfolio of Patents by CUI Global, Inc.

(28th January 2010) New collaboration presents big opportunities for UK SMEs

(14th January 2010) UTEK Pharmalicensing.com Announces New Pricing Model: Pay-per-Click to Expand Listed Opportunities, Extend Reach and Remove Market Barriers

(4th January 2008) UTEK Corporation Acquires Pharmalicensing, Ltd.

(25th July 2007) Pharmalicensing launches 3rd edition of top selling licensing agreement report